ResearcherUniversity of FreiburgActive in the last 2 years
Magdalena Huber
Matched on ORCID iD 0000-0002-2963-0693; OpenAlex author ID A5003119147. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 59
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 3 papers · 2025: none · 2026: 1 paper
Papers 10
- Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. Co-author DOI 10.1016/j.bbcan.2026.189614↗
- DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2023-331854↗
- SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pbio.3002739↗
- Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral T Cell Motility. Co-author DOI 10.3390/cancers17010051↗
- IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Last author DOI 10.1136/gutjnl-2022-327855↗
- IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model. Co-author DOI 10.1158/2326-6066.cir-22-0398↗
- IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. Co-author DOI 10.3390/cells12030456↗
- New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. Co-author DOI 10.1053/j.gastro.2021.04.082↗
- The Immune Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms21197307↗
- miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Co-author DOI 10.1080/2162402x.2016.1160181↗
Closest collaborators
The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thomas Mathias Gress · 9 shared papers, 2016–2026 · strength 1.39
- Paper Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. DOI 10.1016/j.bbcan.2026.189614↗
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. DOI 10.3390/cells12030456↗
- Malte Buchholz · 6 shared papers, 2020–2024 · strength 0.97
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. DOI 10.3390/cells12030456↗
- Paper SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma. DOI 10.1371/journal.pbio.3002739↗
- Christian Alexander Bauer · 5 shared papers, 2020–2024 · strength 0.79
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper IL18 Receptor Signaling Inhibits Intratumoral CD8+ T-Cell Migration in a Murine Pancreatic Cancer Model. DOI 10.3390/cells12030456↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Matthias Lauth · 4 shared papers, 2020–2026 · strength 0.69
- Paper Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. DOI 10.1016/j.bbcan.2026.189614↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Veronika Lutz · 4 shared papers, 2023–2024 · strength 0.65
- Paper Optimized Spheroid Model of Pancreatic Cancer Demonstrates Influence of Macrophage-T Cell Interaction for Intratumoral … DOI 10.3390/cancers17010051↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Corinna Ulrike Keber · 3 shared papers, 2023–2026 · strength 0.60
- Paper Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. DOI 10.1016/j.bbcan.2026.189614↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Anna I. Brichkina · 3 shared papers, 2023–2026 · strength 0.58
- Paper Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. DOI 10.1016/j.bbcan.2026.189614↗
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Felix S.R. Picard · 4 shared papers, 2021–2024 · strength 0.52
- Paper DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. DOI 10.1136/gutjnl-2023-331854↗
- Paper IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in… DOI 10.1158/2326-6066.cir-22-0398↗
- Paper IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. DOI 10.1136/gutjnl-2022-327855↗
- Elena Nasiri · 2 shared papers, 2023–2024 · strength 0.41
- Elke Pogge von Strandmann · 2 shared papers, 2020–2026 · strength 0.40
- Jörg Walter Bartsch · 2 shared papers, 2020–2026 · strength 0.40
- Robert Liefke · 2 shared papers, 2023–2024 · strength 0.30
- Uta‐Maria Bauer · 1 shared paper, 2026 · strength 0.29
- Detlef Klaus Bartsch · 2 shared papers, 2023–2024 · strength 0.29
- Vanessa Zimmer · 1 shared paper, 2024 · strength 0.22
- Benedikt Slusny · 1 shared paper, 2024 · strength 0.22
- Shiv K. Singh · 2 shared papers, 2021–2023 · strength 0.21
- Clara Simon · 1 shared paper, 2024 · strength 0.18
- Carsten Denkert · 1 shared paper, 2024 · strength 0.16
- Peter Duewell · 1 shared paper, 2023 · strength 0.15
- Patrick Michl · 2 shared papers, 2016–2021 · strength 0.14
- Matthias M. Gaida · 1 shared paper, 2023 · strength 0.12
- Philipp Mayer · 1 shared paper, 2023 · strength 0.12
- Lukas Klein · 1 shared paper, 2023 · strength 0.12
- Mengyu Tu · 1 shared paper, 2023 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.